Laxai Therapeutics Private Limited, a struck off private limited company, was established on 15 September 2017 in Hyderabad, Telangana, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U73200TG2017PTC119554. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.20 M.
Formerly known as Laxai Biosimilar Private Limited. It upholds a compliant status. Its leadership includes Ramamanoharprasad Venkataramanayya Maddipatla (Director), Bandoju Srinivas (Additional Director). Past directors included Vamsidhar Maddipatla. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Plot No. 40 & 41, Third Floor Ventureast Plaza, Road No. 2, Financial District, Nanakram, Guda,, Hyderabad, Telangana, 500032.
U73200TG2017PTC119554
119554
15 September 2017
₹1.00 M
₹0.20 M
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Laxai Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramamanoharprasad Venkataramanayya Maddipatla | Director | 15 Sep 2017 | Current |
| Bandoju Srinivas | Additional Director | 13 Jan 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Jan 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Laxai Therapeutics Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 0.2% increase in profit. The company's net worth observed a substantial decline by a decrease of 336.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Laxai Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Laxai Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Laxai Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Laxai Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Bandoju Srinivas was appointed as a Additional Director was appointed as a Additional Director on 13 Jan 2023 & has been associated with this company since 3 years 4 days . was completed.
Progress on Laxai Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
Laxai Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was recorded as a recent event.
The activity Ramamanoharprasad Venkataramanayya Maddipatla was appointed as a Director was appointed as a Director on 15 Sep 2017 & has been associated with this company since 8 years 4 months . was completed.
The activity Laxai Therapeutics Private Limited was registered on 15 Sep 2017 with Roc Hyderabad & aged 8 years 4 months as per MCA records. was completed.
The CIN of Laxai Therapeutics Private Limited is U73200TG2017PTC119554.
Laxai Therapeutics Private Limited is headquartered at Plot No. 40 & 41, Third Floor Ventureast Plaza, Road No. 2, Financial District, Nanakram, Guda,, Hyderabad, Telangana, 500032.
Laxai Therapeutics Private Limited was incorporated on 15 September 2017.
The current directors of Laxai Therapeutics Private Limited are
The primary industry of Laxai Therapeutics Private Limited is Professional, Scientific And Technical.
Laxai Therapeutics Private Limited is unlisted.
The authorized capital of Laxai Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.20 M.
The compliance status of Laxai Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX